Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis

NCT04142749 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: Oltipraz
DRUG: Placebos

Sponsor

PharmaKing